Orilissa

Chemical Nameelagolix sodium
Dosage FormTablet (oral; 250 mg)
Drug ClassReceptor antagonists
SystemFemale reproductive
CompanyAbbVie Inc.
Approval Year2018

Indication

  • To manage the moderate to severe pain associated with endometriosis.
Last updated on 10/14/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Orilissa (Elagolix Sodium) Prescribing Information 2018AbbVie Inc., North Chicago, IL